JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

Home・Akciju saraksts・Talphera Inc.

Talphera Inc.

Slēgts

0.94 -1.05

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.91

Max

0.96

Galvenie mērījumi
By Trading Economics
Darbinieki	13

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+235.05% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 30. marts

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-22M 39M
Iepriekšējā atvēršanas cena	1.99
Iepriekšējā slēgšanas cena	0.94

Talphera Inc. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 30. janv. 20:14 UTC

Iegādes, apvienošanās, pārņemšana

Reddy Ice to Buy Arctic Glacier, DOJ Requires Certain Divestitures

2026. g. 30. janv. 23:47 UTC

Iegādes, apvienošanās, pārņemšana

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

2026. g. 30. janv. 23:47 UTC

Iegādes, apvienošanās, pārņemšana

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

2026. g. 30. janv. 23:47 UTC

Iegādes, apvienošanās, pārņemšana

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

2026. g. 30. janv. 23:47 UTC

Iegādes, apvienošanās, pārņemšana

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

2026. g. 30. janv. 23:47 UTC

Iegādes, apvienošanās, pārņemšana

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

2026. g. 30. janv. 23:47 UTC

Iegādes, apvienošanās, pārņemšana

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

2026. g. 30. janv. 23:47 UTC

Iegādes, apvienošanās, pārņemšana

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

2026. g. 30. janv. 23:47 UTC

Iegādes, apvienošanās, pārņemšana

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

2026. g. 30. janv. 23:41 UTC

Tirgus saruna

Deckers Outdoor Seen as Undervalued -- Market Talk

2026. g. 30. janv. 23:12 UTC

Iegādes, apvienošanās, pārņemšana

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

2026. g. 30. janv. 22:20 UTC

Peļņas

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

2026. g. 30. janv. 22:10 UTC

Tirgus saruna

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

2026. g. 30. janv. 21:50 UTC

Tirgus saruna

Peļņas

Tech, Media & Telecom Roundup: Market Talk

2026. g. 30. janv. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 30. janv. 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 30. janv. 21:42 UTC

Peļņas

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

2026. g. 30. janv. 21:36 UTC

Peļņas

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

2026. g. 30. janv. 21:33 UTC

Peļņas

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

2026. g. 30. janv. 20:42 UTC

Peļņas

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

2026. g. 30. janv. 20:37 UTC

Iegādes, apvienošanās, pārņemšana

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

2026. g. 30. janv. 20:20 UTC

Tirgus saruna

Oil Posts Weekly Gains on U.S.-Iran Tensions -- Market Talk

2026. g. 30. janv. 20:13 UTC

Tirgus saruna

U.S. Natural Gas Futures Rise on Weather-Driven Demand -- Market Talk

2026. g. 30. janv. 19:52 UTC

Peļņas

Visa and Amex Results Point to a Strong Holiday Season for Retailers -- Barrons.com

2026. g. 30. janv. 19:29 UTC

Tirgus saruna

Peļņas

KLA Guidance Only 'Tepid' as Memory Rally Favors Peers -- Market Talk

2026. g. 30. janv. 19:09 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 30. janv. 19:09 UTC

Tirgus saruna

Next Canadian Inflation Release Pushed Back a Day to Not Clash With Holiday -- Market Talk

2026. g. 30. janv. 19:07 UTC

Tirgus saruna

Canada Performing Well Below Economic Potential -- Market Talk

2026. g. 30. janv. 18:46 UTC

Peļņas

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

2026. g. 30. janv. 18:34 UTC

Peļņas

Exxon, Chevron Post Slimmest Annual Profits Since 2021 -- 2nd Update

Salīdzinājums

Cenas izmaiņa

Talphera Inc. Prognoze

Cenas mērķis

By TipRanks

235.05% augšup

Prognoze 12 mēnešiem

Vidējais 3.25 USD 235.05%

Augstākais 3.5 USD

Zemākais 3 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Talphera Inc. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 2 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Talphera Inc. — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Par Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.